ea0035p882 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014
Kushnir Liudmila
, Zabarovskaya Zoya
Objective: The aim was to compare the effectiveness of the bromocriptine and cabergoline treatment of the women with microprolactinomas.Materials and methods: 82 women with microprolactinomas were included in this study (51 patients received bromocriptine (Group 1) and 31 cabergoline (Group 2)) with MRI-control after the first year of treatment (11 women from Group 1; 7 from Group 2), the second (27 women from Group 1; 15 from Group ...